FMP

FMP

Enter

REPH - Recro Pharma, Inc.

photo-url-https://financialmodelingprep.com/image-stock/REPH.jpg

Recro Pharma, Inc.

REPH

NASDAQ

Inactive Equity

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.

2.09 USD

-0.00999999 (-0.478%)

Valuation Date:

Mar 22, 2022 12:00 AM

Share Price on Valuation Date

$2.09

Stock Beta

1.115365

Shares Outstanding

84892200

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep